NANTNEURO LLC has a total of 11 patent applications. Its first patent ever was published in 2016. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are KINNATE BIOPHARMA INC, PHARMA MEDICA AS and RES LAB DR C JANSSEN N V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Spilman Patricia | 10 |
#2 | Buzko Oleksandr | 10 |
#3 | Bredesen Dale | 10 |
#4 | John Varghese | 10 |
#5 | Jagodzinska Barbara | 10 |
#6 | Patricia Spilman | 1 |
#7 | Barbara Jagodzinska | 1 |
#8 | Oleksandr Buzko | 1 |
#9 | Varghese John | 1 |
#10 | Dale Bredesen | 1 |
Publication | Filing date | Title |
---|---|---|
AU2016311502A1 | Compositions for app-selective bace inhibition and uses therfor | |
WO2017035528A1 | Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau |